Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor

Cancer Letters

Volumn 120, Issue 1, 1997, Pages 31-38

  Zhang, Wei ^a,b   Law, Ronald E ^b,c   Hinton, David R ^b,c   Couldwell, William T ^a,b  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b University of California   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Glioma; Hypericin; Invasion; Protein kinase C

Indexed keywords

ANTIVIRUS AGENT; HYPERICIN; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; TAMOXIFEN;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL MOVEMENT; CELLS, CULTURED; ENZYME INHIBITORS; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PERYLENE; PROTEIN KINASE C;

EID: 0030731435     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00287-5     Document Type: Article

References (27)

1. Giese A., Westphal M. Glioma invasion in the central nervous system. Neurosurgery. 39:1996;235-252.
2. Amar A.P., DeArmond S.J., Spencer D.R., Coopersmith P.F., Ramos D.M., Rosenblum M.L. Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion. J. Neurooncol. 20:1994;1-15.
3. Chicoine M.R., Silbergeld D.L. Assessment of brain tumor cell motility in vivo and in vitro. J. Neurosurg. 82:1995;615-622.
4. Hart I.R., Goode N.T., Wilson R.E. Molecular aspects of the metastatic cascade. Biochem. Biophys. Acta. 989:1989;65-84.
5. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
6. Chen C.C. Protein kinase C alpha, delta, epsilon and zeta in C6 glioma cells: TPA induces translocation and down-regulation of conventional and new PKC isoforms but not a typical PKC zeta. FEBS Lett. 332:1993;169-173.
7. Couldwell W.T., Uhm J.H., Antel J.P., Yong V.W. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery. 29:1991;880-887.
8. Pollack I.F., Randall M.S., Solomon D.H., Kristofik M.P., Kelly R.H., Selker R.G., Vertosik F.T. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res. 50:1990;7134-7138.
9. Baltuch G., Couldwell W.T., Villemure J.G., Yong V.W. Protein kinase C inhibitors suppress cell growth in established and low passage glioma cell lines: a comparison between staurosporine and tamoxifen. Neurosurgery. 33:1993;495-501.
10. Couldwell W.T., Hinton D.R., He S., Chen T.C., Sebat I., Weiss M.H., Law R.E. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett. 345:1994;43-46.
11. Couldwell W.T., Hinton D.R., Surnock A.A., DeGiorgio C.M., Weiner L.P., Apuzzo M.L.J., Masri L., Law R.E., Weiss M.H. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin. Cancer Res. 2:1996;619-622.
12. Meruelo D., Lavie G., Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA. 85:1988;5230-5234.
13. Takahashi I., Nakanishi S., Kobayashi E., Nakano H., Suzuki K., Tamaoki T. Hypericin and pseudo-hypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem. Biophys. Res. Commun. 157:1989;755-761.
14. Lenard J., Rabson A., Vanderhoef R. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc. Natl. Acad. Sci. USA. 90:1993;158-162.
15. Couldwell W.T., Gopalakrishna R., Hinton D.R., He S., Weiss M.H., Apuzzo M.L.J., Law R.E. Hypericin: a potential antiglioma therapy. Neurosurgery. 35:1994;705-710.
16. Zhang W., Anker L., Law R.E., Hinton D.R., Gopalakrishna R., Pu Q., Gundimeda U., Weiss M.H., Couldwell W.T. Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro. Clin. Cancer Res. 2:1996;843-846.
17. Repesh L.A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis. 9:1989;192-208.
18. Zhang W., Law R.E., Hinton D.R., Couldwell W.T. Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C. Cancer Lett. 96:1995;31-35.
19. Moser R.P. Surgery for glioma relapse: factors that influence a favorable outcome. Cancer. 62:1988;381-390.
20. L.A. Liotta, Positive and negative molecular regulation of invasion and metastasis, in: J. Brugge, T. Curran, E. Harlow et al. (Eds.), Origin of Human Cancer: A Comprehensive Review, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1991, pp. 833-838.
21. Couldwell W.T., de Tribolet N., Antel J.P., Gauthier T., Kuppner M.C. Adhesion molecules and malignant gliomas: implications for tumorigenesis. J. Neurosurg. 76:1992;782-791.
22. Klemke R.L., Yebra M., Bayna E.M., Cheresh D.A. Receptor tyrosine kinase signaling required for integrin v 5-directed cell motility but not adhesion on vitronectin. J. Cell Biol. 127:1994;859-866.
23. Schwartz G.K., Redwood S.M., Ohnuma T., Holland J.F., Droller M.J., Liu B.C.S. Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J. Natl. Cancer Inst. 82:1990;1753-1756.
24. Tysnes O.-B., Laerum O.D. Differential effects of 12-O-tetradecanoyl-13-phorbol acetate (TPA) on growth, migration and invasion of a human glioma cell line. Anticancer Res. 13:1993;1325-1330.
25. Schwartz G.K., Jiang J., Kelsen D., Albino A.P. Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J. Natl. Cancer Inst. 85:1993;402-407.
26. Mapelli E., Banfi P., Sala E., Sensi M., Supino R., Zunino F., Gambetta R.A. Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int. J. Cancer. 57:1994;281-286.
27. Liu B., Maher R.J., Hannun Y.A., Porter A.T., Honn K.V. 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha. J. Natl. Cancer Inst. 86:1994;1145-1151.